Qiagen (NYSE:QGEN) Valuation Check After Recent Share Price Swings

Qiagen (QGEN) is back on investors’ radar after recent share price swings, with the stock showing a small 1 day gain and ...

QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it will showcase its oncology workflow applications ...
Fierce Biotech

Qiagen launches latest diagnostic for bloodstream infections

Qiagen is moving into syndromic testing for bloodstream infections with the launch of the Netherlands-based diagnostics maker ...
Nasdaq

QIAGEN Stock Gains Following the Acquisition of Genoox

QIAGEN N.V. QGEN recently signed a definitive agreement to acquire Genoox, a provider of AI-powered software that enables clinical labs to scale and accelerate the processing of complex genetic tests.
Seeking Alpha

Qiagen acquires Verogen for $150M to bolster forensics portfolio

Qiagen (NYSE:QGEN) said it completed the acquisition of DNA-biometrics company Verogen for $150M. Verogen develops DNA-based biometric human identification products for analysis of forensic genomic ...
FierceBiotech

Qiagen turns to Sophia Genetics to squeeze more data from next-gen sequencing tests

Qiagen’s next-generation sequencing tests are already used to look for genetic variants that may shed light on an individual’s specific case of cancer and potential treatment options, but the ...
Seeking Alpha

QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software

Acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases Strengthens QIAGEN Digital Insights offering for small and mid-sized labs worldwide ...
Nasdaq

QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to sustainable growth

ESG commitments recognized as strategic business investments bringing value to stakeholders, including customers and employees // Environment: 15% reduction in Scope 1 and 2 emissions in 2023 through ...
Morningstar

QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million

QIAGEN delivers well ahead of schedule on its commitment to return at least $1 billion through end-2028, considering additional ways to increase returns in 2026 and beyond QIAGEN N.V. (NYSE: QGEN; ...
The Globe and Mail

QIAGEN to acquire Parse Biosciences, expanding its Sample technologies portfolio into highly scalable single-cell solutions

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has entered into a definitive agreement to fully acquire Parse Biosciences, a leading provider of scalable, instrument-free ...
Business Wire

QIAGEN Strengthens Growing Portfolio of Applications for Its Digital PCR Platform QIAcuity With New Collaborations

HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced new additions to the growing number of applications for QIAcuity, its ...
The Motley Fool

Here's How Qiagen Trounced Q1 Estimates

Qiagen reported first-quarter revenue of $372.1 million. This reflected a 7% increase from the prior-year period's revenue total of $348.7 million. It also handily beat the average analysts' Q1 ...